abnormal fatty acid oxidation_Clk2<tm1.1Ppgr>/Clk2<tm1.1Ppgr>,Tg(Alb-cre)21Mgn/0

http://metadb.riken.jp/0010953IC57BL6NTacFVBNClk2tm11PpgrClk2tm11PpgrTgAlbcre21Mgn0TgAlbcre21MgnClk2tm11Ppgr

abnormal fatty acid oxidation_Clk2<tm1.1Ppgr>/Clk2<tm1.1Ppgr>,Tg(Alb-cre)21Mgn/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 21, Mark A Magnuson
  http://metadb.riken.jp/db/mgi_rdf/MGI:2176226
• CDC-like kinase 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:1098669

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Clk2<tm1.1Ppgr>/Clk2<tm1.1Ppgr>,Tg(Alb-cre)21Mgn/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Alb-cre)21Mgn|Clk2<tm1.1Ppgr>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6NTac * FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal fatty acid oxidation
  http://purl.obolibrary.org/obo/MP_0010953

文献

http://purl.org/net/cito/citesAsAuthority

• Mitsuhisa. Tabata, et.al., Cdc2-like kinase 2 suppresses hepatic fatty acid oxidation and ketogenesis through disruption of the PGC-1α and MED1 complex., Diabetes, 2014, 63
  http://rdf.ncbi.nlm.nih.gov/pubmed/24458359